Through studies of rats, researchers from the University of Copenhagen may have found the reason behind of a large drop in blood pressure in patients receiving intravenous pain medication.
Most people know about the painkiller paracetamol, commonly used against headaches and ingested orally.
However, in hospitals, paracetamol is administered intravenously. In this way, doctors and nurses can help critically ill patients who are unable to swallow one or more pills.
Furthermore, the substance acts much faster intravenously, and the method allows healthcare professionals to control the doses and the timing of their effect very precisely.
Nevertheless, the intravenous paracetamol has a serious side effect: namely, a temporary large drop in blood pressure.
We now believe that we know the mechanism underlying this dangerous side effect.
Previous studies suggest it is quite a sizable drop. We are, for example, talking about drops in the range of 25-30 mm Hg from a systolic pressure of 120, and we now believe that we know the mechanism underlying this dangerous side effect, says Assistant Professor Thomas Qvistgaard Jepps from the Department of Biomedical Sciences.
He adds that the drop in blood pressure is found in both common and critically ill patients. In the latter category, six out of ten have been reported to experience the side effect. One third of these to such an extent that it requires medical intervention.
This research is rather timely, given the unprecedented COVID-19 crisis and dramatic increase in critically ill patients that maybe receiving intravenous paracetamol in the hospitals to help with pain and fever management.
Despite the statistics, intravenous paracetamol is considered to be a relatively stable drug that is used increasingly in the healthcare system, even though many doctors and nurses are aware of the potential side effects.
We wouldnt want to replace one side effect with another.
On this background, Thomas Qvistgaard Jepps and his team set out to find a cause for the steep drop in blood pressure. As the first in the world, they have now succeeded through studies in rats.
Paracetamol bypasses the liver when administered intravenously, therefore it is metabolised differently to when you ingest it orally, says Thomas Qvistgaard Jepps, adding:
It still gets metabolised, but it happens elsewhere in the body, where the subsequent chemicals can cause an effect that wouldnt normally happen, if the drug was taken orally.
The Assistant Professor emphasises that most people should not be afraid to take painkillers as usual. As long as you still stay within the maximum recommended dose.
More precisely, it appears that the residual products of the painkiller affect some of the potassium channels, which, among other things, regulate how your blood vessels contract and relax, thereby controlling your blood pressure.
Paracetamol bypasses the liver when administered intravenously, therefore it is metabolised differently to when you ingest it orally.
By using drugs that block these potassium channels, specifically, the research team subsequently succeeded in reducing the side effect of the large drop in blood pressure in the test rats.
Because we have identified the mechanism of how the side effect occurs, we believe we are able to offer a potential pharmaceutical design for a new kind of co-therapy: A type of paracetamol infused with another drug that prevents the drop in blood pressure, says Thomas Qvistgaard Jepps.
However, blockers of the potassium channels we have investigated are not yet approved for human consumption and need to be developed and tested properly. We wouldnt want to replace one side effect with another.
The next step of the research group is therefore to investigate how drugs that block the potassium channels may be adapted for humans. They are also investigating alternatives for blocking the potassium channels, for example, by affecting the enzymes involved in metabolising paracetamol outside the liver.
Read the study Acetaminophen (Paracetamol) metabolites induce vasodilation and hypotension by activating Kv7 potassium channels directly and indirectly in the journal Atherosclerosis, Thrombosis and Vascular Biology (ATVB).
The study is the result of a collaboration across departments at the University of Copenhagen assisted by the University of California, Irvine, USA.
The research has received funding from, among others, the Lundbeck Foundation and EUs Horizon 2020 programme.
- Vascular Biology Research Program | Johns Hopkins ... - March 25th, 2020
- Vascular Biology Program | Boston Children's Hospital - March 25th, 2020
- European Vascular Biology Organisation | Advancing human ... - March 25th, 2020
- Study shows similarity in anti-VEGF injection intervals for wet AMD - Ophthalmology Times - March 25th, 2020
- aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform - BioSpace - March 25th, 2020
- Ancient human ancestor 'Little Foot' probably lived in trees, new research finds - WBAP News/Talk - March 23rd, 2020
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Rochester - March 23rd, 2020
- University of Washington Pathology Professor Dies of COVID-19 - The Scientist - March 22nd, 2020
- Who is Sir Patrick Vallance and what is his role in government during coronavirus outbreak? - The Scottish Sun - March 22nd, 2020
- It's Not Only About Neurons - The Good Men Project - March 22nd, 2020
- 'Little Foot' skull reveals how this more than 3 million year old human ancestor lived - HeritageDaily - March 22nd, 2020
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Wareham - March 22nd, 2020
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Dedham - February 23rd, 2020
- UI at 150 & Beyond: 'The Quad was the best no matter what the weather' - Champaign/Urbana News-Gazette - February 22nd, 2020
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Sharon - February 22nd, 2020
- Valentine's Day Matters of the Heart, Biopharma-Style - BioSpace - February 15th, 2020
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 - Galus Australis - February 15th, 2020
- Women Face an Increased Risk of Heart Disease With AgeRunning Can Help - runnersworld.com - February 12th, 2020
- Examining the link between menopause and heart disease risk - Medical News Bulletin - February 10th, 2020
- More than skin deep: the latest innovation in 3D printing - Med-Tech Innovation - February 10th, 2020
- Research Fellow in Vascular Stem Cell Biology job with QUEENS UNIVERSITY BELFAST | 195527 - Times Higher Education (THE) - February 10th, 2020
- Genome editing heralds new era of disease research, therapy - The Augusta Chronicle - January 18th, 2020
- How biology creates networks that are cheap, robust, and efficient - Penn: Office of University Communications - January 18th, 2020
- Scientists revealed the oldest known scorpion on Earth - Tech Explorist - January 18th, 2020
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 Dagoretti News - Dagoretti News - January 18th, 2020
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related... - January 14th, 2020
- Sandy Bottom wetlands to receive protection for 'national ecological significance' - Citizen Times - January 14th, 2020
- Why biotech is a boon for patients and investors - Spear's WMS - January 14th, 2020
- Vascular Biology | Surgery Research | Michigan Medicine ... - January 2nd, 2020
- UCC currently taking applicants for 21 jobs with some incredible pay - Cork Beo - January 2nd, 2020
- Growing up Tyrannosaurus rex: Osteohistology refutes the pygmy Nanotyrannus and supports ontogenetic niche partitioning in juvenile Tyrannosaurus -... - January 2nd, 2020
- Top Technical Advances of 2019 - The Scientist - December 29th, 2019
- 9 Harvard researchers named AAAS Fellows Harvard - Harvard Gazette - November 27th, 2019
- Bethesda Health Physician Group Welcomes Fellowship-Trained Endocrine Surgeon Jessica L. Buicko, MD, to Its Team - The Boca Raton Tribune - November 27th, 2019
- Germ-free lungs of newborn mice are partially protected against hyperoxia - The Mix - November 27th, 2019
- JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) - Yahoo Finance - November 27th, 2019
- Another Study Suggests E-cigarettes Hurt Heart Health More Than Regular Cigarettes - Science Times - November 21st, 2019
- Cleveland Clinic awarded $12 million by NIH to study the link between gut microbes and heart disease - Crain's Cleveland Business - November 21st, 2019
- Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock - Business Wire - November 21st, 2019
- Growing Organs in the Lab: One Step Closer to Reality - BioSpace - November 21st, 2019
- US Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy - The... - November 21st, 2019
- Vascular biology Department of Surgery College of ... - November 19th, 2019
- E-Cigarettes Take a Dangerous Toll on Heart Health - DocWire News - November 19th, 2019
- Another health warning for e-cigarette users that has nothing to do with lung disease - MarketWatch - November 19th, 2019
- Submerged Vegetation Mirrors Coast's Health - Coastal Review Online - November 19th, 2019
- University of Maryland and DOD collaborate to study Tick-borne Infections using 3-D models of human blood vessels - Outbreak News Today - November 19th, 2019
- 'The Blob': This mysterious 'smart' slime can solve puzzles and make decisions - CNBC - October 24th, 2019
- Michal Wszola: We Expect to Transplant the Bioprinted Bionic Pancreas in Three to Five Years - 3DPrint.com - October 24th, 2019
- UNSW skin cancer researcher Levon Khachigian hit with string of retractions - ABC News - October 16th, 2019
- Research Officer/ Postdoctoral Researcher - The Conversation AU - October 16th, 2019
- Four health projects at Boston Childrens Hospital that could help adults - The Boston Globe - September 30th, 2019
- Cardiovascular Repair And Reconstruction Devices Market Global Industry Insights by Top Vendors, Growth, Revenue and Forecast Outlook 2019-2025 -... - September 26th, 2019
- Quinn Capers IV, MD - TCTMD - September 24th, 2019
- Oklahoma new hires and promotions announced - Oklahoman.com - September 24th, 2019
- Nature up close: Life in the Humboldt Penguin National Reserve - CBS News - September 24th, 2019
- Prediabetes, Diabetes Comorbidities Tied to Sex Differences - MedPage Today - September 24th, 2019
- A Snail as Fast as a Bullet, and Other Darwin-Defying Marvels - Discovery Institute - September 24th, 2019
- Medication and Exercise to Prevent Muscle Loss - Next Avenue - September 24th, 2019
- Awards - esm-evbo2019.org - April 23rd, 2019
- Plant Physiology | Basic Biology - March 12th, 2019
- pvb2019.org Plant Vascular Biology Conference 2019 - January 31st, 2019
- Vascular Biology - January 22nd, 2019
- Vascular Biology 2019 - NAVBO - December 20th, 2018
- Vascular Biology 2018 - NAVBO - December 19th, 2018
- Vascular Biology | Society for Vascular Surgery - November 30th, 2018
- Vascular Biology Chicago Medicine - November 30th, 2018
- PPARs and Their Emerging Role in Vascular Biology ... - November 26th, 2018
- 2019 Cerebral Vascular Biology Conference - cvent.com - November 21st, 2018
- Vascular Biology - NAVBO - November 20th, 2018
- Lower vascular plant | biology | Britannica.com - November 18th, 2018
- Vascular Biology | Pulmonary, Allergy, Sleep & Critical ... - November 16th, 2018
- esm-evbo2019.org - Menu - July 27th, 2018
- Biology 211: Taxonomy of Flowering Plants - June 7th, 2018
- 2019 Vascular Cell Biology Conference GRC - May 26th, 2018
- Vascular Discovery: From Genes to Medicine - May 7th, 2018
- Vascular Biology Conferences | Vascular Surgery ... - May 5th, 2018
- APVBO-Asia Pacific Vascular Biology Organization Conference - April 18th, 2018
- Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell ... - April 13th, 2018